Human versican/PG-M/PG-350 ELISA kit

Code CSB-E11884h
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Alternative Names
Chondroitin sulfate proteoglycan 2 ELISA Kit; Chondroitin sulfate proteoglycan core protein 2 ELISA Kit; Chondroitin sulfate proteoglycan core protein; cartilage ELISA Kit; CSPG2 ELISA Kit; CSPG2_HUMAN ELISA Kit; ERVR ELISA Kit; GHAP ELISA Kit; Glial hyaluronate binding protein ELISA Kit; Glial hyaluronate-binding protein ELISA Kit; Large fibroblast proteoglycan ELISA Kit; PG-M ELISA Kit; PGM ELISA Kit; VCAN ELISA Kit; Versican ELISA Kit; Versican core protein ELISA Kit; Versican proteoglycan ELISA Kit; WGN 1 ELISA Kit; WGN ELISA Kit; WGN1 ELISA Kit
Uniprot No.
Homo sapiens (Human)
Sample Types
serum, plasma, tissue homogenates.
Detection Range
0.04 ng/ml-30 ng/ml.
0.04 ng/ml.
Assay Time
Sample Volume
Detection Wavelength
450 nm
Research Area
Signal Transduction
Assay Principle






and FAQs
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx

The human VCAN ELISA kit (CSB-E11884h) is designed for the quantitative measurement of human VCAN protein in samples. It shows excellent specificity for human VCAN. It uses the bi-antibody sandwich enzyme immunoassay technique. This assay employs a biotin-conjugated VCAN antibody that recognizes the analyte bound by the immobilized VCAN antibody, forming an antibody-analyte-antibody complex. The immune complex is further detected by avidin-conjugated HRP. The TMB solution is added into the wells and turns blue and finally turns yellow after the addition of the stop solution. Solution color develops in proportion to the amount of VCAN in the sample. The O.D. value is measured using a microplate reader at 450 nm and is used to determine the concentration of the human VCAN in the sample.

VCAN is a large extracellular matrix (ECM) proteoglycan that is significantly increased expressed and accumulated during inflammation in most diseases. It plays an essential role during development and is an important component of tissue inflammation caused by infection and tissue injury. VCAN interacts with its receptors such as CD44, PSGL-1, and TLR2, initiating a signaling cascade that affects the phenotypes of immune and inflammatory cells. It is also implicated in multiple processes of cancer development, including proliferative signaling, evasion of growth-suppressor pathways, modulation of cell death, promotion of neoangiogenesis, and tissue invasion & metastasis.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

(From Uniprot)
May play a role in intercellular signaling and in connecting cells with the extracellular matrix. May take part in the regulation of cell motility, growth and differentiation. Binds hyaluronic acid.
Gene References into Functions
  1. VCAN expression in colorectal cancer and its role in cetuximab resistance PMID: 28320945
  2. miR-135a-5p can suppress cell progress including cell proliferation, migration, and invasion in thyroid carcinoma by targeting VCAN 3 '-UTR. PMID: 28869452
  3. This study highlights the oncogenic role of VCAN in renal cell carcinogenesis and suggests that this gene has therapeutic and/or biomarker potential for renal cell cancer. PMID: 28242813
  4. Interleukin-17A promotes tongue squamous cell carcinoma metastasis by activating miR-23b/versican pathway in the tumor microenvironment. PMID: 28035060
  5. The macular dysfunction on mfERG was profound and of early onset. A heterozygous mutation in intron 7 of the VCAN gene (c.4004-1G > A) was found. PMID: 29071374
  6. Versican V0 and V1 isoforms were upregulated in the uterine leiomyomas of symptomatic versus asymptomatic women. Abundant cleaved versican was detected in leiomyoma and myometrium, as well as in myometrial and leiomyoma cell lines. VCAN siRNA did not effect cell proliferation, apoptosis, or smooth muscle markers, but reduced ESR1 and PR-A expression. PMID: 28323982
  7. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression PMID: 28481899
  8. Removal or knockdown of versican may be a possible therapeutic strategy for increasing deposition of insoluble elastin and stimulating repair of elastic fibers in COPD lung. PMID: 28138236
  9. human myeloma tumors displaying CD8(+) infiltration/aggregates underwent VCAN proteolysis at a site predicted to generate a glycosaminoglycan-bereft N-terminal fragment. PMID: 27259980
  10. versican decreases in follicular dermal papilla as an aging-associated change of human hair follicles PMID: 27697422
  11. Data indicate that serum versican levels were significantly decreased in polycystic ovary syndrome (PCOS) patients, and that serum ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin motif-1) and versican levels were significantly and positively correlated with each other. PMID: 27908842
  12. the G1 domain of versican can regulate the organization of pericellular hyaluronan and affect phenotype of cultured human dermal fibroblasts PMID: 27126822
  13. Results highlight an important role for versican in regulating the expression and assembly of elastin and the phenotype of leiomyosarcoma cells. PMID: 26723257
  14. Versican localizes to the nucleus in proliferating mesenchymal cells and suggest role in mitotic spindle organization during cell division. PMID: 26395512
  15. VCAN and VEGF were associated with survival in CRC patients with PM after CRS and HIPEC PMID: 26873137
  16. Versican is a novel modulator of hepatic fibrosis. PMID: 26752747
  17. versican mRNA is up-regulated much more highly (>600 fold) by long term hypoxia (5 days) than by 1 day of hypoxia. PMID: 26057378
  18. Versican V1 overexpression induces a myofibroblast-like phenotype in cultured fibroblasts. PMID: 26176948
  19. Versican upregulation in Sezary cells alters growth, motility and resistance to chemotherapy. PMID: 25915825
  20. Versican isoform V1 is associated with high-grade gliomas. PMID: 25064688
  21. Significant elevation of VCAN and its associated molecules imply their role in multiple myeloma PMID: 25623955
  22. Our results suggest that TGF-beta1 up-regulates versican expression by suppressing miR-143, and this pathway is important for osteosarcoma cell migration and invasion. PMID: 25562163
  23. Circulating monocytes may contribute to the fibrotic process in a subset of systemic sclerosis patients by amplifying a positive feedback loop consisting of versican, CCL2, and the influx of monocytes PMID: 23845159
  24. Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects. PMID: 24240681
  25. Versican regulates the growth of leiomyosarcoma tumors. PMID: 25320080
  26. these data suggest that versican regulates the development of peritoneal metastasis originating from cells and spheroids. PMID: 24999371
  27. The ADAMTS5 ancillary domain and specific chondroitin sulfate chains of versican are required for proteolysis. PMID: 25122765
  28. Versican expression in tumor epithelial cells predicts a good prognosis for gastric cancer patients. PMID: 25275064
  29. Lack of versican expression is associated with recurrence in colon cancer. PMID: 22711178
  30. CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion. PMID: 24180670
  31. FoxQ1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression. PMID: 24005989
  32. A novel c.4004-6T>A nucleotide substitution at the acceptor splice site of intron 7 of the VCAN gene that segregated with the Wagner disease phenotype, was identified. PMID: 24174867
  33. Cleaved versican G1 domain-containing fragments (VG1F) can be recaptured by microfibrils through VG1F homotypical interactions to enhance hyaluronan recruitment to microfibrils. PMID: 23963449
  34. altered balance of VCAN splice variants in combination with reduction in glycosaminoglycan protein modifications as pathogenic mechanisms in Wagner syndrome PMID: 22739342
  35. Letter/Case Report: disease causing versican mutation in Wagner syndrome. PMID: 23571384
  36. versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and subsequent vitamin D-dependent mechanisms which promote ovarian tumor progression in vitro PMID: 23424670
  37. No association has been found between polymorphisms of rs251124 and rs3767137 loci of CSPG2 and HSPG2 genes and intracranial aneurysm in the selected population. PMID: 23568740
  38. Wnt/beta-catenin signal transducting system regulates dermal papilla cell aggregative growth through modifying versican expression by means of acting on the versican gene upstream promoter. PMID: 23099107
  39. these results demonstrate that versican V0 and V1 isoforms play important roles in HCC development and that versican mRNAs compete with endogenous RNAs in regulating miRNA functions. PMID: 23180826
  40. Mesenchymal cells derived from keloid lesion (KL) cells exhibit above-normal versican production. PMID: 22951719
  41. the glioblastoma cell line U87 stably transfected with versican isoform V2 formed tumors containing extensive vasculature PMID: 23201264
  42. renal versican expression was significantly upregulated as compared to corresponding controls. These data show for the first time an association of renal versican isoform V0 and V1 expression with progressive renal disease. PMID: 23024773
  43. Studies indicate that E-cadherin and versican are involved in cancer epithelial-mesenchymal transitions and metastasis. PMID: 23002209
  44. Tissue microarray analysis revealed that epithelial expression of versican had significant relations to lymph node metastasis and pathological stages of breast cancer PMID: 22318369
  45. E(2) treatment increases the amount of dermal HA and versican V2 via paracrine release of EGF, which may be implicated in the pro-proliferative and anti-inflammatory effects of E(2) during photoaging. PMID: 22493503
  46. The major isoforms expressed by gastric carcinoma & gastric cell lines were V0 & V1. V1 was higher in gastric carcinoma. Abnormally expressed versican & its isoforms participate in the progress of gastric carcinoma triggered by IL-11. PMID: 22393310
  47. RhoGDI2 suppresses lung metastasis in mouse models by reducing the expression of isoforms V1 and V3 of the proteoglycan versican, which is require for lung metastasis. High versican levels portended poor prognosis in patients with bladder cancer. PMID: 22406535
  48. Hyaluronan and versican play a role in T-cell trafficking and function in inflamed tissues. PMID: 22155153
  49. Versican is a key component of the provisional wound repair ECM that is expressed following injury to valvular interstitial cells. PMID: 21546273
  50. the G1 and G3 domains of versican were upregulated and LTBP-4 was downregulated in breast cancer stroma PMID: 21505857

Show More

Hide All

Involvement in disease
Wagner vitreoretinopathy (WGVRP)
Subcellular Location
Secreted, extracellular space, extracellular matrix. Cell projection, cilium, photoreceptor outer segment. Secreted, extracellular space, extracellular matrix, interphotoreceptor matrix.
Protein Families
Aggrecan/versican proteoglycan family
Tissue Specificity
Expressed in the retina (at protein level). Cerebral white matter and plasma. Isoform V0: Expressed in normal brain, gliomas, medulloblastomas, schwannomas, neurofibromas, and meningiomas. Isoform V1: Expressed in normal brain, gliomas, medulloblastomas,
Database Links

HGNC: 2464

OMIM: 118661

KEGG: hsa:1462

STRING: 9606.ENSP00000265077

UniGene: Hs.643801

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1